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Abstract
Objectives: Open abdomen technique with negative pres-
sure therapy (NPT) is widely used in patients with severe
abdominal sepsis. The aim of this study was to evaluate
cytokine clearance in serumandperitoneal fluidduringNPT.
Methods: This prospective pilot study included six pa-
tientswith severe abdominal sepsis requiring discontinuity
resection and NPT for 48 h followed by planned reopera-
tion. Cytokines (IL6, IL8, IL10, TNFalpha, and IL1beta)
were measured in the serum and peritoneal fluid during
index operation, on postoperative days 0, 1, and 2.
Results: Concentrations of cytokines in peritoneal fluid
were higher than in serum. IL10 showed a clearance both in
serum (to 16.6%, p=0.019) and peritoneal fluid (to 40.9%,
p=0.014). IL6 clearedonly in serum (to 24.7%, p=0.001)with
persistently high levels in peritoneal fluid. IL8 remained
high in both serum and peritoneal fluid. TNFalpha and
IL1beta were both low in serum with wide range of high
peritoneal concentrations. Only TNFalpha in peritoneal
fluid showed significant differences between patients with
ischemia vs. perforation (p=0.006).
Conclusions: The present pilot study suggests that cyto-
kines display distinct patterns of clearance or persistence in
the peritoneal fluid and serumover the first 48 h of treatment
in severe abdominal sepsis with NPT.
Keywords: abdominal negative pressure therapy; acute
abdomen; cytokine clearance; damage control surgery;
emergency surgery.
Introduction
Abdominal sepsis is associated with significant morbidity
and mortality due to multiorgan failure caused by systemic
inflammatory response [1–3]. In abdominal sepsis, a local
source such as hollow organ perforation or mesenteric
ischemia results in local and systemic inflammatory
response. Pathophysiologically, the loss of intestinal
continuity in the case of intestinal perforation or the loss
of barrier functionof thebowelwall in the caseofmesenteric
ischemia lead to an active secretion of pro-inflammatory-
mediator-rich ascites by the peritoneum [4–8]. Studies have
indicated that local inflammatory response may be stronger
than systemic inflammatory response in the case of
abdominal sepsis [9–12]. Hence, the inflammatory ascites is
suspected to be an important motor for systemic inflam-
mation and hence an important determinator of multiorgan
failure [4, 9, 10, 13, 14].
Cytokines are regulators of acute or chronic infection and
immune response. The pro-inflammatory cytokine Interleukin
6 (IL6) is a potent mediator of sepsis and is associated with an
increased risk of organ dysfunction and mortality in patients
with abdominal sepsis [15–20]. Furthermore, IL6was shown to
reflect overall cytokine cascade activation [21]. Interleukin 8
(IL8) is a chemokine produced by macrophages, but also
epithelial and endothelial cells, mediates chemotaxis of neu-
trophils and stimulates phagocytosis in the innate immune
response [22]. Oxidative stress is a potent inducer of IL8
secretion, making it a key pro-inflammatory mediator of
localized inflammation [23]. IL10 is an anti-inflammatory
cytokine that enhances antibody response by CD4+ T-cell
activation, costimulatory molecules on macrophages and
suppression of secretion of pro-inflammatory cytokines trig-
gered by bacterial products and lipopolysaccharide [24–28]. It
is elevated post abdominal surgery and decreases in the
postoperative course of patients without complications [29].
Tumor necrosis factor alpha (TNFalpha) is a pro-inflammatory
cytokine and enhances cellular immune response. TNFalpha
levels are elevated in intra-abdominal sepsis [30]. Levels
decrease in patients without postoperative complications,
whereas patients with complications show a secondary rise
preceding the complication [29]. Interleukin 1 beta (IL1beta) is
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an important pro-inflammatory cytokines modulating mono-
cyte activation and pro-inflammatory signaling. It was shown
to be elevated in patients with gram-negative bacteremia and
correlate with the development and severity of sepsis, multi-
organ failure, death, and sepsis susceptibility [31–33].
Open abdomen technique is widely used in patients
with severe abdominal sepsis to avoid abdominal compart-
ment syndrome and facilitate 2nd look laparotomy [34–39].
After damage control surgery (discontinuity resection of
affected bowel), the abdomen is temporarily closed to
provide visceral coverage [38, 40], and the patient stabilized
on the ICU. The patient is taken back to the operating room
48 h later to restore intestinal continuity. Several groups
including our institution adopted this systematic 2nd
look strategy in unstable patients with abdominal sepsis
[36, 41–47]. In addition to simple visceral coverage, a
temporary abdominal closure using negative pressure
therapy (NPT) might help clearing pro-inflammatory
cytokines and potentially reducing peritoneal and systemic
inflammation and thus improving outcomes [9, 13, 14, 48–52].
However, little is known about clearance of cytokines from
serum and peritoneal fluid under this therapy.
The aim of this pilot study was to describe and compare
cytokine concentrations in serum and peritoneal fluid in the
early postoperative period inpatientswith abdominal sepsis
and NPT. The study explores the following questions (I) are
cytokine concentrations in the peritoneal fluid higher than
in the serum, (II) do cytokines have similar kinetics in the
peritonealfluid and serum, and (III) are kinetics of clearance
of cytokines dependent of the source of abdominal sepsis.
Materials and methods
This prospective pilot study included six patients with severe
abdominal sepsis requiring discontinuity resection and abdominal
NPT for 48 h followed by 2nd look laparotomy with planned bowel
reconstruction. The study was funded by an educational grant from
the University Hospital; no industry sponsored funds were received.
Funding was available for six patients.
The five cytokines IL6, IL8, IL10, TNFalpha, and IL1beta were
chosen due to their important role in the inflammatory response
to intra-abdominal sepsis. Peritoneal levels were obtained in order
to determine local inflammatory response and serum levels in order to
determine systemic inflammatory response. Cytokines were measured
in the serum and peritoneal fluid during index operation, upon arrival
in intensive care unit (ICU) on postoperative day (POD) 0, on POD1,
and on POD2. Peritoneal fluid was acquired by sampling intra-
abdominal fluid at the initiation of index operation (timepoint 1) and
by the aspiration of peritoneal liquid from the abdominal vacuum
container (timepoints 2 to 4). Blood samples were taken from venous
blood draws at the same timepoints. Cytokines were analyzed in
triplicates by Enzyme Linked ImmunoSorbent Assay (ELISA).
In addition to cytokines, laboratory parameters including elec-
trolytes, glucose and proteins were measured in serum and peritoneal
fluid, aswell as CRP, procalcitonin, and lactate in the serumat the four
timepoints. Baseline characteristics of patients including age, sex,
American Society of Anesthesiologists (ASA) score, Acute Physiology
And Chronic Health Evaluation (APACHE)-II score, and Sequential
Organ Failure Assessment (SOFA) score, as well as clinical outcome
including length of hospital stay, length of ICU stay, 30-daymortality,
and comprehensive complication index were registered.
Individual values of cytokineswere plotted in spaghetti plots and
compared for peritoneal and serum values. Variability between pa-
tients (intersubject variability) was calculated for each cytokine.
Cytokine clearancewas described as difference in percentage (%) from
baseline (timepoint 1, index operation) to timepoints 2–4 (POD0,
POD1, and POD2) and plotted in bar charts. Differences in clearance
patterns over all timepointswere calculated. In a subanalysis, patients
with mesenteric ischemia and bowel perforation were compared with
respect to reduction of cytokine levels from timepoint 1 to timepoint
4 (ΔPOD2) for both peritoneum and serum. Similarly to cytokines,
additionally measured laboratory parameters were plotted in spa-
ghetti plots and compared for their peritoneal and serum values. In
accordance to cytokines, difference between ischemia and perforation
was calculated for these additional laboratory parameters.
Statistics and analysis
Continuous parametric variables were reported as mean ± SD and
compared by using unpaired student’s t-test (two-tailed, α of 0.05,
confidence level 95%) in the case of absence of additional timepoint
factor or by using two-way ANOVA test (α of 0.05, confidence level
95%, Geisser-Greenhouse correction) for additional timepoint com-
parisonwith ischemia and perforation as column factors (3 subjects as
subcolumns) and timepoints as row factors, and by using ANOVA
multiple comparisons (Turkey correction) to compare two individual
timepoints. Continuous nonparametric variables were reported as
median+ range and compared by usingMann-Whitney test (unpaired,
two-tailed, αof 0.05, confidence level 95%). Categorical variableswere
reported as frequency (%) and compared by use of Fisher’s exact test
(two-sided, α of 0.05, confidence level 95%). Statistical analysis and
graphs were performed by using GraphPad Prism 8.3.0.
Results
The study cohort included three patients with intestinal
perforation and three patients with mesenteric ischemia.
Pertinent baseline demographics and outcomes did not
significantly differ for these two groups and are detailed
in Table 1. Two patients in the perforation group died,
one patient in septic shock on POD2 before 2nd look lap-
arotomy and intestinal reconstruction, and one on POD15
due to respiratory decompensation. According to the
institutional treatment algorithm, four patients had intes-
tinal reconstruction on POD2 and one received a terminal
ileostomy after initial total colectomy, as an ileorectal
anastomosis was not considered beneficial for this patient.
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Early postoperative course of cytokines revealed
higher values in peritoneal fluid compared to serum con-
centrations (Figure 1). Values of serum IL8 (p<0.0001)
and peritoneal IL1beta (p=0.004) were marked by a high
intersubject variability.
A kinetics of clearance was found for IL10 in the serum
(p=0.019) and peritoneal fluid (p=0.014) and IL6 in the
serum (p=0.001), while peritoneal IL6 and peritoneal IL8
levels remained persistently high (Figure 2). Serum IL8
levels decreased in five patients but increased in one pa-
tient. This was the patient who deceased on POD2. Serum
values of TNFalpha and IL1beta were very low or even
undetectable at most timepoints, which was not the case
for their peritoneal counterparts.
When comparing patients with ischemia to patients
with perforation with respect to reduction of cytokine level
between timepoint 1 and timepoint 4 (ΔPOD2), only peri-
toneal TNFalpha levels showed a significant difference of
ΔPOD2 for the two groups (Figure 3).
In contrast to cytokines with higher concentrations
in the peritoneal fluid as compared to the serum, elec-
trolytes (sodium p=0.07 and potassium p=0.96) in
the peritoneal fluid and serum were not significantly
different, and values for glucose (p=0.008), protein
(p<0.0001), and albumin (p<0.0001) were even higher in
the serum. On the other hand, chloride (p=0.019) and
lactate dehydrogenase (LDH) levels (p=0.0007) were
higher in the peritoneal fluid than in the serum. None of
the aforementioned additionally measured laboratory
parameters was significantly different between ischemia
and perforation.
Maximal values for CRP were noted on POD1 (mean
289 mg/L (SD 56 mg/L) for ischemia and mean 247 mg/L
(SD 111 mg/L) for perforation) and were not significantly
different for the two groups (p=0.97 for peak values and
p=0.95 for all timepoints). CRP was the only marker to
show an increasing kinetics over the four timepoints
(p=0.002). The other additionally measured parameters
including glucose, sodium, potassium, chloride, protein,
albumin, LDH, and amylase had no statistically signifi-
cant kinetics over the first 48 h. Procalcitonin peaks found
on POD1 (mean 9.4 μg/L (SD 10.1 μg/L) for ischemia and
mean 25.5 μg/L (SD 18.8 μg/L) for perforation) also did
not differ significantly between the two groups (p=0.74
for peak values and p=0.11 for all timepoints). Lactate
peaks were found during index operation and were
not significantly different in the ischemia and perfora-
tion group (3.1 mmol/L (SD 1.3 mmol/L) vs. 3.7 mmol/L
(SD 0.8 mmol/L); p=0.95 for peak values and p=0.35 for
all timepoints).
Table : Baseline characteristics and clinical outcomes of patients with negative pressure therapy for abdominal sepsis.
Diagnosis Ischemia Ischemia Ischemia Perforation Perforation Perforation
Age, years      
Sex Male Male Male Female Male Female
ASA score      
APACHE-II score      
SOFA score      
Length of stay, days      
Length of ICU stay, days      
-day mortality      
Comprehensive complication index . . .  . 
Each column represents one patient. ASA, American Society of Anesthesiologists; APACHE, Acute Physiology And Chronic Health Evaluation;
SOFA, Sequential Organ Failure Assessment; ICU, intensive care unit.
Figure 1: Cytokine levels in peritoneal fluid and serumof patients under negative pressure therapy. Spaghetti plots for levels of cytokines IL10,
IL6, IL8, TNFalpha, and IL1beta are depicted for each timepoint (1=index operation, 2=POD0 arrival ICU, 3=POD1, 4=POD2). Each line
represents one patient with blue lines corresponding to peritoneal fluid levels and red lines corresponding to serum levels. p-Values compare
peritoneal and serum levels for all six patients with respect to their timepoints.
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Figure 2: Clearance pattern of cytokines in peritoneal fluid and
serum. For each cytokine, means and standard deviations are
represented for each timepoint with their corresponding
percentages in relation to timepoint 1 (index operation). p-Values
are calculated comparing kinetics over all four timepoints.
Discussion
Pro-inflammatory cytokines induced by different endo- or
exogenous triggers play an important role in initiating in-
flammatory response and regulating host defense. In
abdominal sepsis, this cytokine cascade is initiated upon a
direct toxic effect of pathogens like bacteria and intestinal
fluid after bowel perforation or upon release of toxic me-
tabolites like lactate, reactive oxygenmetabolites, and nitric
monoxide in mesenteric ischemia. The pro-inflammatory
cytokine release serves to contain and resolve the inflam-
matory focus through the activation of local and systemic
inflammatory responses, however, an overexpression of
pro-inflammatory cytokines contributes to the development
of organ dysfunction and poor outcomes. This pilot study
provides information on local and systemic levels and
clearance patterns of cytokines in patients with abdominal
sepsis requiring bowel discontinuity resection and under-
going negative pressure therapy.
Cytokine-mediated inflammatory response was com-
partmentalized, with a higher local response in the perito-
neal cavity compared to the systemic response in the present
study. Similarly, higher peritoneal cytokine concentrations
were measured in patients undergoing planned relapar-
otomy for severe secondary peritonitis with a 19-fold higher
concentration of TNFalpha and a 993-fold higher concen-
tration of IL6 in the peritoneal exudate compared to the
serum [9]. A study analyzing systemic and peritoneal cyto-
kines levels (in the liquid of peritoneal drain) after abdom-
inal surgery for diverse indications showed significantly
higher TNFalpha, IL6, and IL10 peritoneal values [10].
Another study, also sampling peritoneal fluid from abdom-
inal drains of patients undergoing elective intestinal re-
sections or pancreatic surgery [11] displayed high peritoneal
TNF alpha and peritoneal IL1beta concentrations within the
first 12 h after operation, while serum concentrations were
undetectable. The same was observed in the present study.
Apart from one patient, all serum TNF alpha and INF1 beta
levels were undetectable or near undetectable. Furthermore,
an enhancedperitoneal inflammatory response following gut
ischemia reperfusion was shown in animal reperfusion
models [12]. These data suggest that the compartmentali-
zation for TNFalphaand IL1beta is even stronger than for the
other measured interleukins, and that the peritoneum acts
as barrier for cytokine control. Studies have suggested
peritoneal mesothelial cells as well as peritoneal macro-
phages and leukocytes as important sources of intra-
abdominal cytokine release [7, 8]. A specific immune cell
recruitment postsurgery with respect to natural killer cells,
monocytes, natural killer T cells, and CD5+ B cells in the
peritoneal fluid and blood has been demonstrated [53].
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The present pilot study suggested distinct clearance
patterns for different cytokineswith a rapid IL10 clearance in
both peritoneum and serum, an IL6 clearance in the serum
only, as opposed to persistently high levels in the perito-
neum and a serum clearance of IL8 in five out of six patients,
with the patient deceased shortly after the last 48 h sampling
timepoint having an increase of IL8 serum levels, whilst IL8
levels stayed high for all patients. A study with 19 patients
undergoing open abdominal treatment for secondary peri-
tonitis showed no correlation of serum and peritoneal cyto-
kine concentrations over time [13]. Similar to the present
data, in this study, peritoneal IL6 levels did not decrease
within the first hours after lavage, and serum and peritoneal
IL8 concentrations were stable at 24 h. However, whereas
patients in the mentioned study showed no changes in IL10
levels over time, a continuous decrease for both peritoneal
and serum levels was found in the present study. Although
there were no statistically significant differences in cytokine
concentrations for survivors vs. nonsurvivors, survivors had
relatively large individual changes of peritoneal IL8
compared to non-survivors, which might go in line with the
one patient in the present study showing serum IL8 increase
associated with lethal outcome. An animal study on rats
being injected with feces and bacteria intraperitoneally
showed a strong correlation between peritoneal IL6 and IL10
levels with mortality [51], and a study on 17 patients under-
going planned relaparotomy for abdominal infection
showed decreasing endotoxin and TNFalpha levels in sur-
vivors with persistent elevation in nonsurvivors [9].
Subgroup analysis in the present study suggested no
difference of levels and clearance in patients with ischemia
and perforation for all cytokines except TNFalpha levels
which were significantly higher in patients with bowel
perforation. Similarly, a study looking at intraperitoneal
cytokine response after different indications for major
abdominal surgery found higher peritoneal TNFalpha levels
in patients undergoing rectal surgery [10]. An exogenous
bacterial trigger as in the case of bowel perforation or rectal
surgery possibly induces a stronger peritoneal TNFalpha
release as opposed to endogenous metabolites released
after mesenteric ischemia. Of note, TNFalpha is one of
the earliest released pro-inflammatory mediator and
possibly the only cytokine affected by this discrepancy
as opposed to mediators released later in the cytokine
cascade.
This study applied a negative pressure vacuum system
for abdominal coverage after emergency abdominal
discontinuity resection. A standardized damage control
strategy in hemodynamically unstable patients and pa-
tients with acidosis or lactatemia due to abdominal sepsis
is adopted in our institution. These patients undergo rapid
damage control surgery with discontinuity resection fol-
lowed by NPT and planned reoperation at 48 h. The role of
NPT in cytokine clearance is not yet pertinently elucidated.
Animal studies suggested an improved fluid clearance,
reduced systemic inflammatory response, and better out-
comes with NPT [14]. In humans, a study comparing
ABThera vs. Baker’s vacuum pack with respect to blood
and peritoneal cytokine levels after operation for abdom-
inal injury or intra-abdominal sepsis did not show differ-
ences in plasma concentrations of different cytokines
including IL6, IL1beta, IL8, IL10, and IL12 for the two
comparative groups [48]. Patients of the ABThera group
had, however, significantly lower 90-day mortality rates. A
further study on patients with NPT with ABThera vs.
Baker’s vacuum-packing displayed significantly higher
30-day primary fascial closure rates and lower 30-day
mortality among patients for the ABThera group with a
Figure 3: Comparison of reduction in cytokine levels between ischemia and perforation. (A) Values for peritoneum, (B) Values for serum.
For each cytokine, means are represented for timepoint 1 (index operation) in black and for timepoint 4 (POD2) in white, in order to display the
reduction between timepoint 1 and timepoint 4 (ΔPOD2). For each cytokine, left bar corresponds to ischemia and right bar corresponds to
perforation. p-Values compare ΔPOD2 between ischemia and perforation.
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higher likelihood of survival in a multivariate logistic
regression analysis [49]. A comparison of NPT vs. Bogota
bag showed faster abdominal closure rate and earlier
discharge from ICU for NPT [50]. Looking at vacuum-
assisted closure vs. on demand laparotomy for secondary
peritonitis, no difference in serum levels and clearance
pattern of IL8 and peritoneal levels and clearance pattern
of TNFalpha, as well as mortality was observed in the two
groups [54]. It remains currently unknown if cytokines are
directly related to improved outcomes.
In addition to cytokines, this study measured labo-
ratory parameters, both in the peritoneum and serum.
Sodium and potassium did not differ between serum and
peritoneal fluids and protein and albumin levels were
higher in the serum than the peritoneal liquid. The peri-
toneal liquid probably represents a transudate rather than
exudate, and the liquid seems to be correctly evacuated
by the vacuum system rather than concentrated in the
abdominal cavity before evacuation. This would under-
line that the higher concentration of cytokines in the
peritoneal fluid is not due to a concentration change of the
liquid but an actual compartmentalization of cytokine
release in the peritoneum.
Main limitation of this study is the small sample of only
six patients. In fact, high variations between patients could
be noted for some measurements. The present study has
therefore to be regarded as pilot to provide baseline data.
In summary, high peritoneal cytokine concentrations
and a distinct clearance of different cytokines were found
both in serum and peritoneal fluid of patients with abdom-
inal sepsis and intestinal discontinuity resection treated by
negative pressure therapy. Further investigations are needed
to evaluate (I) whether faster cytokine clearance associates
with better clinical outcomes, (II) if NPT can help to improve
cytokine clearance in serum and peritoneal fluid, and (III)
if different triggers of abdominal sepsis have diverse effects
on early cytokine cascade as opposed to later released
metabolites.
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